Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paramyxoviridae Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04623047
What this trial is testing

Infection Watch Study

Who this might be right for
COVID-19 Respiratory InfectionRespiratory Syncytial Virus InfectionsRhinoviral Infections+1 more
Duke University 10,034
Early research (Phase 1)Study completedNCT00308412
What this trial is testing

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 45
Large-scale testing (Phase 3)Study completedNCT06551181
What this trial is testing

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 2,620
Early research (Phase 1)Study completedNCT01290419
What this trial is testing

Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 150
Early research (Phase 1)Ended earlyNCT02890381
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Study completedNCT05398796
What this trial is testing

Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults

Who this might be right for
Nipah Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT02196285
What this trial is testing

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella

Who this might be right for
RubellaMeasles
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 30
Early research (Phase 1)Study completedNCT01968083
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 51
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Early research (Phase 1)Study completedNCT06033612
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 50
Large-scale testing (Phase 3)Study completedNCT00984295
What this trial is testing

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,913
Not applicableNot Yet RecruitingNCT07235397
What this trial is testing

Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 1
Early research (Phase 1)Study completedNCT02794870
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Early research (Phase 1)Study completedNCT02201303
What this trial is testing

Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 40
Not applicableStudy completedNCT00013871
What this trial is testing

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Who this might be right for
HIV InfectionsHepatitis BMeasles+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT01537198
What this trial is testing

Surveillance of Synagis in Korean Pediatric Patients

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie (prior sponsor, Abbott) 618
Early research (Phase 1)Study completedNCT05178901
What this trial is testing

Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Who this might be right for
Nipah Virus Infection
Public Health Vaccines LLC 60
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Not applicableEnded earlyNCT00138255
What this trial is testing

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT02114268
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 342
Next Page